How can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?
Alexander Kriz
Advertisement
Alexander Kriz is Director at Executive Insight.
Articles by Alexander Kriz
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
2
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience
5